Biaryl compounds as serine protease inhibitors
US6699994B1 · kind B1 · utility
54Cited by
0References
21Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 23, 2002 |
| Grant date | Mar 2, 2004 |
| Priority date | — |
| Expiry date | May 11, 2022 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07C2601/18
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compounds of formula (I) are useful as inhibitors of trypsin like serine protease enzymes such as thrombin, factor VIIa, factor Xa, TF/FVIIa, and trypsin. These compounds could be useful to treat and/or prevent clotting disorders, and as anticoagulating agents.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.